全球细胞分级分离市场规模、份额、趋势和成长分析报告（2026-2034）

预计细胞分级市场将从 2025 年的 3.065 亿美元成长到 2034 年的 6.5802 亿美元，2026 年至 2034 年的复合年增长率为 8.86%。

随着生物医学研究、免疫疗法和诊断技术对细胞群体的精确高通量分离的需求日益增长，细胞分离市场正进入高速成长阶段。未来的平台将整合微流体技术、人工智慧驱动的影像识别和自动化技术，以实现研究和临床应用中的高纯度、高活性和高通量分离。利用声学、介电和光学操控的新型无标定分离技术将提高效率并减少对样品的影响。

高速、多参数萤光活化细胞分选 (FACS) 系统凭藉其增强的光学系统、高速雷射扫描和即时数据分析功能，支援复杂的实验流程。与生物资讯流程和云端分析的集成，可促进下游分子谱分析、单细胞定序和预测建模。实验室自动化和机器人样品处理减少了人工干预，提高了实验的可重复性。

未来成长将主要由个人化医疗、干细胞疗法和先进免疫疗法的拓展所驱动。透过结合创新分选技术、人工智慧辅助分析和自动化，细胞分选市场将在加速研发、治疗方法开发和精准医疗方面发挥核心作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球细胞分级市场：依产品分类

• 市场分析、洞察与预测
• 细胞分选仪
• 试剂和耗材
• 服务

第五章 全球细胞分级市场：依技术划分

• 市场分析、洞察与预测
• 基于萤光的液滴分离
• 细胞的磁激活
• MEMS－微流体技术

第六章 全球细胞分级市场：依应用划分

• 市场分析、洞察与预测
• 出于研究目的
• 临床应用

第七章：全球细胞分离市场：依最终用途划分

• 市场分析、洞察与预测
• 研究机构
• 医学院和学术机构
• 製药和生物技术公司
• 医院和临床检查室

第八章 全球细胞分级市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • BD
  • Bio-Rad Laboratories Inc
  • Danaher Corporation
  • Sony Group Corporation
  • Miltenyi Biotec
  • On-Chip Biotechnologies Co. Ltd
  • Cytonome/ST LLC
  • Union Biometrica Inc
  • Thermo Fisher Scientific Inc
  • UFluidix

The Cell Sorting Market size is expected to reach USD 658.02 Million in 2034 from USD 306.50 Million (2025) growing at a CAGR of 8.86% during 2026-2034.

The cell sorting market is entering a high-growth phase as biomedical research, immunotherapy, and diagnostics increasingly rely on precise, high-throughput isolation of cell populations. Future platforms will integrate microfluidic technologies, AI-driven image recognition, and automation to achieve high purity, viability, and throughput for research and clinical applications. Emerging label-free sorting techniques using acoustic, dielectric, and optical manipulation will enhance efficiency and reduce sample perturbation.

High-speed, multi-parameter fluorescence-activated cell sorting (FACS) systems will benefit from enhanced optics, faster laser scanning, and real-time data analytics to support complex experimental workflows. Integration with bioinformatics pipelines and cloud-based analytics will facilitate downstream molecular profiling, single-cell sequencing, and predictive modeling. Lab automation and robotic sample handling will reduce manual intervention and enhance reproducibility.

Future growth will be driven by the expansion of personalized medicine, stem cell therapies, and advanced immunotherapies. By combining innovative sorting technologies, AI-assisted analytics, and automation, the cell sorting market will play a central role in accelerating research, therapeutic development, and precision healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Cell Sorters
• Reagents and Consumables
• Services

By Technology

• Fluorescence-based Droplet Cell Sorting
• Magnetic-activated Cell Sorting
• MEMS - Microfluidics

By Application

• Research Applications
• Clinical Applications

By End Use

• Research Institutions
• Medical Schools and Academic Institutions
• Pharmaceutical and Biotechnology Companies
• Hospitals and Clinical Testing Laboratories

COMPANIES PROFILED

• BD, BioRad Laboratories Inc, Danaher Corporation, Sony Group Corporation, Miltenyi Biotec, Onchip Biotechnologies Co Ltd, CytonomeST LLC, Union Biometrica Inc, Thermo Fisher Scientific Inc, uFluidix
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CELL SORTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Cell Sorters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents and Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CELL SORTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Fluorescence-based Droplet Cell Sorting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Magnetic-activated Cell Sorting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. MEMS - Microfluidics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CELL SORTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Research Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinical Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CELL SORTING MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Medical Schools and Academic Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Hospitals and Clinical Testing Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CELL SORTING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CELL SORTING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 BD
  • 10.2.2 Bio-Rad Laboratories Inc
  • 10.2.3 Danaher Corporation
  • 10.2.4 Sony Group Corporation
  • 10.2.5 Miltenyi Biotec
  • 10.2.6 On-Chip Biotechnologies Co. Ltd
  • 10.2.7 Cytonome/ST LLC
  • 10.2.8 Union Biometrica Inc
  • 10.2.9 Thermo Fisher Scientific Inc
  • 10.2.10 UFluidix